Oncotelic Therapeutics (OTLC) Interest Expenses (2019 - 2026)
Oncotelic Therapeutics' Interest Expenses was $318,292 in Q2 2026, up 53.2% from $207,780 a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Interest Expenses (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Oncotelic Therapeutics' Interest Expenses was $628,772 through Jun 30, 2026, up 58.1% year-over-year; for FY2025, it came in at $370,000, up 1.9% from FY2024.
- Interest Expenses shows a five-year compound annual growth rate of -28.6% (FY2020 to FY2025).
- In earlier years, Interest Expenses was $363,000 in FY2024 (-65.3%), $1.04 million in FY2023 (-64.8%), $2.97 million in FY2022 (+48.3%) and $2 million in FY2021 (+0.2%).
- The Q2 2026 figure marks the highest quarterly Interest Expenses since Q1 2023.
- Compared with a year earlier, Interest Expenses was higher in three of the last six quarters, with an average decline of 6.9%.
- The best year-over-year quarter for Interest Expenses over five years was Q2 2022 (growth of 152.3%); the worst was Q3 2024 (a decline of 97.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | - |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 462.00 Mn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 435.00 Mn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | - |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 318,292.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 318,292.00 |
| Dec 31, 2025 | 94,000.00 |
| Sep 30, 2025 | 8,700.00 |
| Jun 30, 2025 | 207,780.00 |
| Mar 31, 2025 | 93,000.00 |
| Dec 31, 2024 | 93,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | -58,709.00 |
| Mar 31, 2024 | 234,709.00 |
| Dec 31, 2023 | 207,686.00 |
| Sep 30, 2023 | 185,424.00 |
| Jun 30, 2023 | 257,396.00 |
| Mar 31, 2023 | 394,278.00 |
| Dec 31, 2022 | 971,882.00 |
| Sep 30, 2022 | 606,824.00 |
| Jun 30, 2022 | 1.09 Mn |
| Mar 31, 2022 | 297,464.00 |
| Dec 31, 2021 | 602,564.00 |
| Sep 30, 2021 | 445,363.00 |
| Jun 30, 2021 | 433,979.00 |
API Access
Oncotelic Therapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();